GGrantIndex
← Leaderboards

Matthew O'Donnell

University Of Michigan At Ann Arbor

$8,467,174
Attributed
$10,598,345
Total exposure
8
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY200524
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$10,598,345 · 8

By mechanism

R01$10,145,194 · 6
R21$453,151 · 2

Top collaborators

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Ultrasonography

Research focus

UltrasonographyDetectionImageTissuesHuman SubjectBlood VesselsImage EnhancementImage GuidedNovel StrategiesDimensionsBioimaging /Biomedical ImagingMachine LearningBiomechanicsAreaInjectionsCanis FamiliarisMotionAnimalsEnvironmentMechanicsBloodContrast MediaClinical ApplicationCause Of Death

Grant awards (21)

Real-time spectroscopic photoacoustic/ultrasound (PAUS) scanner withsimultaneous fluence and motion compensation to guide and validateinterventions: system development and preclinical testing.$674,182
R01 · FY2024 · EB · contact PI
Real-time spectroscopic photoacoustic/ultrasound (PAUS) scanner withsimultaneous fluence and motion compensation to guide and validateinterventions: system development and preclinical testing.$732,665
R01 · FY2023 · EB · contact PI
q4DE: A Biomarker for Image-Guided, Post-MI Hydrogel Therapy$786,529
R01 · FY2022 · HL
Real-time spectroscopic photoacoustic/ultrasound (PAUS) scanner withsimultaneous fluence and motion compensation to guide and validateinterventions: system development and preclinical testing.$730,097
R01 · FY2022 · EB · contact PI
q4DE: A Biomarker for Image-Guided, Post-MI Hydrogel Therapy$790,095
R01 · FY2021 · HL
Real-time spectroscopic photoacoustic/ultrasound (PAUS) scanner withsimultaneous fluence and motion compensation to guide and validateinterventions: system development and preclinical testing.$747,636
R01 · FY2021 · EB · contact PI
q4DE: A Biomarker for Image-Guided, Post-MI Hydrogel Therapy$795,348
R01 · FY2020 · HL
q4DE: A Biomarker for Image-Guided, Post-MI Hydrogel Therapy$824,785
R01 · FY2019 · HL
Non-invasive trapping and imaging of circulating tumor cells in the peripheral va$442,239
R01 · FY2016 · EB · contact PI
Non-invasive trapping and imaging of circulating tumor cells in the peripheral va$430,670
R01 · FY2015 · EB · contact PI
Non-invasive trapping and imaging of circulating tumor cells in the peripheral va$424,926
R01 · FY2014 · EB · contact PI
Non-invasive trapping and imaging of circulating tumor cells in the peripheral va$450,334
R01 · FY2013 · EB · contact PI
Optoacoustic Transduction for High-Frequency Ultrasound$330,055
R01 · FY2005 · EB
Ultrasonic Imaging of LIOB in Dendrimer Nanocomposites$229,500
R21 · FY2005 · EB
Microwave Induced Thermal Imaging$223,651
R21 · FY2005 · EB
CAN IVUS MANAGE CORONARY ARTERY INTERVENTIONS$346,874
R01 · FY2003 · HL
CAN IVUS MANAGE CORONARY ARTERY INTERVENTIONS$339,186
R01 · FY2002 · HL
CAN IVUS MANAGE CORONARY ARTERY INTERVENTIONS$332,857
R01 · FY2001 · HL
ELASTICITY IMAGING FOR DETECTION OF RENAL PATHOLOGY$317,729
R01 · FY2001 · DK
CAN IVUS MANAGE CORONARY ARTERY INTERVENTIONS$340,507
R01 · FY2000 · HL
ELASTICITY IMAGING FOR DETECTION OF RENAL PATHOLOGY$308,480
R01 · FY2000 · DK